By: Staff Reporter From: genomeweb.com Investigators involved in the third phase of the Electronic Medical Records and Genomics Network (EMERGE III) have tracked the frequency and type of secondary or incidental findings that occur in diverse participants who were profiled with targeted panel sequencing, uncovering reportable findings in some 3 percent of those individuals. “These important findings serve as a …